Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -41,087 | -407,196 | -297,874 | -172,482 |
| Depreciation Amortization | N/A | 3,927 | 13,917 | N/A | N/A |
| Accounts receivable | N/A | -39 | 24,590 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 2,669 | 1,805 | N/A | N/A |
| Other Working Capital | N/A | -14,558 | 161,914 | N/A | N/A |
| Other Operating Activity | 0 | -29,599 | 6,505 | 168,956 | 88,157 |
| Operating Cash Flow | $N/A | $-78,687 | $-198,465 | $-128,918 | $-84,325 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 130,000 | N/A | N/A |
| PPE Investments | N/A | -12,118 | -42,193 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -411 | -3,207 | N/A | N/A |
| Other Investing Activity | 0 | -220,382 | -282,790 | -291,495 | -185,823 |
| Investing Cash Flow | $N/A | $-232,500 | $-194,983 | $-291,495 | $-185,823 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 459 | 628,082 | N/A | N/A |
| Other Financing Activity | 0 | -434 | -1,419 | 303,102 | 301,959 |
| Financing Cash Flow | $N/A | $25 | $626,663 | $303,102 | $301,959 |
| Exchange Rate Effect | N/A | 10 | 34 | -44 | 715 |
| Beginning Cash Position | N/A | 688,938 | 455,689 | 455,689 | 455,689 |
| End Cash Position | N/A | 377,786 | 688,938 | 338,334 | 488,215 |
| Net Cash Flow | $N/A | $-311,152 | $233,249 | $-117,355 | $32,526 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -78,687 | -198,465 | -128,918 | -84,325 |
| Capital Expenditure | N/A | -12,118 | -42,197 | N/A | N/A |
| Free Cash Flow | 0 | -90,805 | -240,662 | -128,918 | -84,325 |